<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-046407</identifier>
<setSpec>0210-0010</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Autosomal recessive diseases with mental retardation</dc:title>
<dc:description xml:lang="en">Introduction. Autosomal recessive diseases with mental retardation are disorders that affect autosomes, and theirgenetic expression occurs in individuals who are homozygotic for a mutation, while heterozygotic subjects are unaffectedcarriers. If both parents are carriers, the theoretical possibility of their children also being carriers is 50%, the risk of thechildren being affected by the disease is 25%, and there is a 25% chance of their being healthy. They are an important sourceof mental deficiencies and inborn errors of metabolism (IEM) are some of their characteristic syndromes. Development. Thegenetic disorders known as IEM can be classified according to the metabolism they affect, that is, purines, pyrimidines, aminoacids, and so on. One of the lysosomal disorders is Tay-Sachs disease, which is rare among the general population but is veryfrequent in populations with a high rate of consanguinity, such as the Ashkenazi Jews. One of the most notable disordersaffecting the metabolism of amino acids is the case of phenylketonuria due to mutations in the phenylalanine hydroxylase gene(PAH). It accounts for 0.5-1% of mental diseases and appears with a frequency rate of between 1/11,500 and 1/14,000 innewborn infants. Its early diagnosis through neonatal screening programmes makes it possible to start administering aphenylalanine-free diet and thus prevent mental retardation. Conclusions. Knowledge of this kind of autosomal diseases withneurological involvement, together with their correct and early diagnosis, makes it possible to establish suitable treatmentregimens in some cases and to carry out genetic counselling in all of them</dc:description>
<dc:creator>Tellería, J. J</dc:creator>
<dc:creator>Blanco, A</dc:creator>
<dc:creator>Diego-Otero, Y. de</dc:creator>
<dc:creator>Palencia, R</dc:creator>
<dc:creator>López, B</dc:creator>
<dc:creator>Fernández-Carvajal, I</dc:creator>
<dc:creator>Alonso, M</dc:creator>
<dc:creator>Durán, M</dc:creator>
<dc:creator>Navarro, N</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. Las enfermedades autosómicas recesivascon retraso mental son alteraciones que afectan a los autosomas ysu expresión genética se da en individuos que son homocigotos parauna mutación, y los heterocigotos son portadores no afectos.Con ambos padres portadores, la posibilidad teórica de que sushijos sean portadores es del 50%, un riesgo de 25% de hijos afectadospor la enfermedad, y otro 25% sanos. Son origen importantede deficiencias mentales, y algunos síndromes característicos sonlos errores congénitos del metabolismo (ECM). Desarrollo. Los trastornosgenéticos de los ECM se pueden clasificar de acuerdo con elmetabolismo alterado: purinas, pirimidinas, aminoácidos, etc. Dentrode los trastornos lisosomales se encuentra la enfermedad de Tay-Sachs, que es rara en la población general, pero con una alta frecuenciaen poblaciones de gran consanguinidad, como los judíosasquenazí. Entre las alteraciones que afectan al metabolismo delos aminoácidos, es especialmente relevante el caso de la fenilcetonuriapor mutaciones en el gen de fenilalanina hidroxilasa (PAH).Supone un 0,5-1% de las enfermedades mentales, y aparece conuna frecuencia de l/11.500-1/14.000 en recién nacidos. Su diagnósticoprecoz con los programas de cribado neonatal permite instaurarla administración de una dieta alimenticia carente de fenilalaninay evitar el retraso mental. Conclusiones. El conocimiento ycorrecto y precoz diagnóstico de este tipo de enfermedades autosómicascon afectación neurológica permite establecer unas pautasadecuadas de tratamiento en unos casos y de asesoramiento genéticoen todos</dc:description>
<dc:source>Rev Neurol;42(supl.1): s39-s43, ene. 2006. ilus</dc:source>
<dc:identifier>ibc-046407</dc:identifier>
<dc:title xml:lang="es">Enfermedades autosómicas recesivas con retraso mental</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d2918</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30000^s22033</dc:subject>
<dc:subject>^d8838^s22033</dc:subject>
<dc:subject>^d25123</dc:subject>
<dc:subject>^d14040^s22033</dc:subject>
<dc:type>article</dc:type>
<dc:date>200601</dc:date>
</metadata>
</record>
</ibecs-document>
